Skip to main content
Equibles

COMMONWEALTH EQUITY SERVICES, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 312272 WALTHAM, MA
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$1,889,004
+$864,759 QoQ
Shares Held
407,113
+10.9% QoQ
Ownership
0.404%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 98 holders
Holding Since
Sep 2021
20 quarters on record

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. GALT ranks #14 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 50,813 $25,240,341
2 TGTX
Tg Therapeutics, Inc.
 186,987 $10,273,065
3 REGN
Regeneron Pharmaceuticals, Inc.
 14,671 $9,147,955
4 EXEL
Exelixis, Inc.
 105,998 $5,767,351
5 TARS
Tarsus Pharmaceuticals, Inc.
 79,888 $5,028,150
6 MRNA
Moderna, Inc.
 66,546 $4,660,216
7 KRYS
Krystal Biotech, Inc.
 12,116 $4,503,153
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 55,170 $4,496,906

All Filings in GALT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,889,004 407,113
2026-03-31 $1,024,245 367,113
2025-12-31 $1,389,839 334,096
2025-09-30 $1,250,380 294,901
2025-06-30 $602,223 285,414
2025-03-31 $314,229 257,565
2024-12-31 $173,528 134,518
2024-09-30 $1,328,976 483,264
2024-06-30 $1,092,373 483,351
2024-03-31 $276,620 115,741
2023-12-31 $174,940 105,386
2023-09-30 $204,522 106,522
2023-06-30 $146,191 101,522
2023-03-31 $213,196 101,522
2022-12-31 $114,719 101,522
2022-09-30 $62,298 38,220
2022-06-30 $50,068 38,220
2022-03-31 $43,312 26,902
2021-12-31 $34,987 16,902
2021-09-30 $46,179 11,902